Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|February 10, 2023
Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosisLoreto Martinez-Gonzalez, Ana MartinezJournal of Enzyme Inhibition and Medicinal Chemistry|January 11, 2024
Druggable cavities and allosteric modulators of the cell division cycle 7 (CDC7) kinaseElisa Rojas-Prats, Loreto Martinez-Gonzalez, Carmen Gil, et al.Expert Opinion on Investigational Drugs|April 28, 2026
Innovative therapies under clinical development for ALS treatment: Small moleculesLoreto Martinez-Gonzalez, Cecilia Sanchez-Santos, Chi-Chen Sarah Huang, et al.Chemmedchem|June 30, 2026
Novel Xanthene Derivatives for Neuroprotection in Alzheimer's Disease-Synthesis and Biological AssessmentMiguel Maia, Ana Rita Monteiro, Márcia S Martins, et al.Frontiers in Molecular Neuroscience|August 25, 2023
TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer's disease patientsLoreto Martinez-Gonzalez, Eva P Cuevas, Carlota Tosat-Bitrián, et al.Journal of Medicinal Chemistry|March 16, 2026
Brain Permeable SGK1 Inhibitors: A Promising Therapeutic Strategy for Neurodegenerative DiseasesEnrique Madruga, Alfonso Garcia-Rubia, Carlos Sanchez-Nuñez, et al.Journal of Neurochemistry|July 7, 2020
Therapeutic potential of novel Cell Division Cycle Kinase 7 inhibitors on TDP-43-related pathogenesis such as Frontotemporal Lobar Degeneration (FTLD) and amyotrophic lateral sclerosis (ALS)Gabriela Vaca, Loreto Martinez-Gonzalez, Ana Fernandez, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|October 27, 2018
Computer-aided molecular design of pyrazolotriazines targeting glycogen synthase kinase 3M Lourdes Sciú, Victor Sebastián-Pérez, Loreto Martinez-Gonzalez, et al.Bioorganic Chemistry|July 26, 2024
7-Amino-[1,2,4]triazolo[1,5-a][1,3,5]triazines as CK1δ inhibitors: Exploring substitutions at the 2 and 5-positionsIlenia Grieco, Davide Bassani, Letizia Trevisan, et al.ACS Chemical Neuroscience|September 26, 2018
A Focused Library of Psychotropic Analogues with Neuroprotective and Neuroregenerative PotentialElisa Uliassi, Luis Emiliano Peña-Altamira, Aixa V Morales, et al.Pageof 2